The penny stock market has been quiet for a long time, and the speculation has not been carried out. Transactions with a slight "selling point" have become a hot topic.
The most "noise" change of hands in recent days is when Xiao Ruoyuan, a current affairs commentator, sold Yihui Finance (8079) to "Cordyceps King" Chen Ende at a "low price".
Earlier this month, Chen Ende completed the comprehensive acquisition offer of Yihuan Finance, and his shareholding rose to more than 50%, and he officially became a major shareholder.
It was originally thought that Yihuan's finance changed hands and the dust settled, but recently, a mysterious person swept the market and became the second largest shareholder, which stimulated the stock to double in five days, causing the "sniper" shock!
This mysterious person is called Chen Hongkai, and he is not active in the stock market.
"Hong Kong 01" interviewed Chen about the shareholding. He took the opportunity to express his goodwill, saying that he admired the business model of "Cordyceps King" and the track record of "Royal Medicine Hall". I bet two or three million!"
In May of this year, Yihuan Finance (8079) was sold at a 20% discount by the original shareholder Xiao Ruoyuan to the "Cordyceps King" Chen Ende.
(Video screenshot)
In May of this year, Xiao Ruoyuan, the original shareholder of Yihuan Finance (8079), "sold an offer" to Chen Ende, Chairman of Stillzhi Group and "Cordyceps King". The placing price of 0.08 yuan was 20% lower than the 0.1 yuan before the suspension. After the sale was completed, Xiao Ruoyuan Only hold 0.67%, and cash out a total of 6.58 million yuan.
Afterwards, Chen Ende made a general takeover offer in accordance with the listing rules, and effectively obtained 16% of the shares offered by Yihuan Finance. Together with the 34.24% equity acquired earlier, Chen Ende currently holds a total of about 50.24% of the shares of Yihuan Finance.
After Chen Ende reached an unconditional offer for Yihuan Finance, I thought it was "no joke". Unexpectedly, the stock has changed again recently. The stock price doubled from 0.16 yuan to 0.32 yuan on the 5th trading day.
The increase is so surging, is it possible that Cheng Yaojin is killed halfway, and a battle for equity hegemony is being staged?
Sure enough, according to the disclosure of the Hong Kong Stock Exchange, a mysterious person named Chen Hongkai swept 12.22 million shares of Yihui Finance on July 8, with a shareholding ratio of 5.08%, although the shareholding ratio is 5.08%. The average price is 0.225 yuan, and the capital involved is only about 2.75 million yuan, but it is 1.81 times higher than the "cost price" of "Cordyceps King".
Chen Hongkai, the second largest shareholder of Yihuan Finance, believes in "value investment" and now supports Chen Ende with real money.
(provided by respondents)
Share to "support" Cordyceps King
It is amazing to be so aggressive in buying a founder at the beginning of the transition between the old and the new.
Looking through the information, Chen Hongkai, 42 years old, is a registered physiotherapist and an executive director of Lijun Group (8360), and is usually not active in the stock market.
He admitted to reporters that he bought 5% of Yihuan Finance. The reason was not "competing for a company" as speculated by the outside world, but to "support" the actions of the latest major shareholder, making Yihuan Finance a "Cordyceps King Concept Stock".
"I read the news and saw that the king of Cordyceps, Chen Ende, became a shareholder. In the past, his royal medicine hall went from a founder to the main board to a market value of 5 billion! It proves that he has good financial skills in addition to doing business!"
Chen Hongkai, who is a physiotherapist himself, has only invested in stocks "part-time" in recent years. He revealed that he used to start a physiotherapy company that mainly serves elderly homes, and he once earned over 10 million yuan in good times.
However, after the Legislative Council Rabu ordered the government to delay the approval of the social welfare project, the company eventually turned from profit to loss and closed down.
Chen Ende said that he will focus on doing a good job in the existing business of Yihuan, hoping that the experience in the retail industry can bring new impetus to the company.
(file picture)
Counting down the "masterpieces" of investments
The business lost money, and Chen Hongkai once again returned to his old business as a physiotherapist. He started as a wage earner, and then moved to the stock market. The "outrageous work" was a bold purchase of ChiNext stocks. It may be difficult for the outside world to understand, but Chen Hongkai said that his personal investment history also has many "bright spots".
He revealed that his investment philosophy is value investing and "following the trend", but unlike ordinary retail investors who listen to the financial commentator "Pai Ba", he follows famous shareholders and looks for market players with a good investment track record in the market. on a boat."
Earlier, I bought Sing Tao (1109) because of Cai Jiazan's investment in shares, and another investment was to buy Lansheng Pharmaceutical (0503) at 1.6 yuan. After that, the group announced a dividend of 1.55 yuan. The return is close to one. times.
This time, he bet on Yihui Finance, he said: "The name of Chen Ende is enough for me to bet two or three million! The previous acquisition offer was 0.08 yuan, and the stock price once fell to 0.11 yuan. The net current asset value of the book is 0.48 yuan per share, and the family is at a discount!" As for whether to increase his holdings in the future, Chen Hongkai said that it depends on the stock price, and he does not rule out increasing his holdings. Let's think about it first. I'm thinking of holding it in the long-term, but if it reaches the target price of 0.48 yuan in the short-term, I will put it!"
Regarding the silver bullet support of "fans", "Cordyceps King" did not disclose whether he knew Chen Hongkai, but told "Hong Kong 01": "I will focus on doing a good job in the existing business of Yihuan, hoping that the experience in the retail industry can bring new opportunities to the company. Momentum. The increase in shareholders’ holdings reflects a positive outlook for Yihuan, and hopes to further participate in the company’s business operations in the future to bring better returns to investors.”